Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Amicus Therapeutics Company Profile (NASDAQ:FOLD)

Consensus Ratings for Amicus Therapeutics (NASDAQ:FOLD) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.33 (43.68% upside)

Analysts' Ratings History for Amicus Therapeutics (NASDAQ:FOLD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/20/2014Cowen and CompanyBoost Price Target$14.00ViewTweet This Rating  Share This Rating on StockTwits
7/1/2014Janney Montgomery ScottUpgradeNeutral -> Buy$2.50 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
7/1/2014Leerink SwannUpgradeMarket Perform -> Outperform$2.50 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
6/30/2014JPMorgan Chase & Co.UpgradeNeutral -> OverweightViewTweet This Rating  Share This Rating on StockTwits
5/6/2014Leerink SwannLower Price Target$3.00 -> $2.50ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Leerink SwannBoost Price Target$2.50 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
11/21/2013Janney Montgomery ScottDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
11/21/2013JPMorgan Chase & Co.DowngradeOverweight -> NeutralViewTweet This Rating  Share This Rating on StockTwits
10/24/2013Leerink SwannDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Janney Montgomery ScottInitiated CoverageBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
1/2/2013Janney Montgomery ScottInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/21/2012WedbushDowngradeNeutral -> Underperform$6.00 -> $1.50ViewTweet This Rating  Share This Rating on StockTwits
12/20/2012Leerink SwannLower Price TargetOutperform$9.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
12/20/2012JPMorgan Chase & Co.Lower Price TargetOverweight$9.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
12/20/2012CapstoneDowngradeBuy -> Hold$3.00ViewTweet This Rating  Share This Rating on StockTwits
12/20/2012Canaccord GenuityLower Price TargetBuy$11.00 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
11/1/2012CapstoneInitiated CoverageBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/1/2012 forward)
Discuss Amicus Therapeutics